Resultados de la búsqueda 31-40 of 3691 for supplement combinations
This research is being done to evaluate the safety and tolerability of the new drug, axatilimab, in combination with olaparib (a standard of care treatment) ...
The purpose of this study is to evaluate how well combination chemotherapy works in treating patients with newly diagnosed stage II-IV diffuse anaplastic Wilms ...
... combination with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone given in 21-day treatment cycles (R-CHOP-21) and CC99282 in combination ...
Participants in the treatment arm will take the supplement drug for 2 days. ... A combination of mutation screening in clinically ... A combination of ...
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer. Jacksonville, Fla. This study is researching an ...
Accessed April 16, 2024. FDA 101: Dietary supplements. U.S. Food and Drug Administration. https://www.fda.gov/consumers/consumer-updates/fda-101-dietary- ...
Or it may be used in combination with other treatments to improve results. Bispecific antibodies versus monoclonal antibodies. Bispecific antibodies are a step ...
... combination with other cancer treatments for patients with relapsed/refractory multiple myeloma (RRMM). Phase Ib Study of Axatilimab in Combination with ...
... combinations and overall survival; to define the patient experience of men with advanced prostate cancer and identify unmet needs in their treatment; and to ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?